ERBB2 and gastric cancer: In addition, one study showed that HER2 gene amplification, as determined by the HER2/CEP17 ratio and HER2 gene copy number, could significantly predict improved OS and treatment response in advanced GC patients undergoing trastuzumab-based chemotherapy [55].